| NCOIX | RITEX | NCOIX / RITEX | |
| Total Expense Ratio | 0.77 | 0.70 | 110% |
| Annual Report Gross Expense Ratio | 0.84 | 0.70 | 120% |
| Fund Existence | 16 years | 24 years | - |
| Gain YTD | 2.648 | 1.559 | 170% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 250 | 40,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 568M | 28.6B | 2% |
| Annual Yield % from dividends | 7.43 | 6.40 | 116% |
| Returns for 1 year | 6.62 | 5.11 | 130% |
| Returns for 3 years | 29.51 | 28.02 | 105% |
| Returns for 5 years | 25.43 | 24.70 | 103% |
| Returns for 10 years | 72.04 | 75.18 | 96% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSGFX | 25.68 | 0.18 | +0.71% |
| Morgan Stanley Inst Global Franchise C | |||
| BRUHX | 19.05 | 0.07 | +0.37% |
| MFS Blended Research Value Equity I | |||
| SUFCX | 42.53 | 0.03 | +0.07% |
| NAA Mid Growth C | |||
| FSLZX | 54.87 | 0.04 | +0.07% |
| Fidelity Advisor Stock Selec Mid Cp Z | |||
| TAMVX | 38.28 | -0.13 | -0.34% |
| T. Rowe Price Mid-Cap Value Adv | |||